Lv5
1540 积分 2025-10-24 加入
The Challenge of CMC Regulatory Compliance for Biopharmaceuticals
1个月前
已完结
AI-driven discovery of GPNMB CAR T cells as a multi-cancer therapy
2个月前
已完结
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
2个月前
已完结
Lipid nanoparticle composition directs systemic trafficking and tissue-specific T cell immunity after intramuscular injection
2个月前
已完结
Cell-autonomous control of CAR signaling and receptor shedding via ADAM17-mediated proteolysis
3个月前
已完结
Biopharmaceutical Landscape
3个月前
已关闭
Harvest Process and Affinity Resin Selection Impacts on Adeno-Associated Virus Residual Host Cell Protein Retention
3个月前
已完结
B lymphocyte protein factories produced by hematopoietic stem cell gene editing
3个月前
已完结
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study
4个月前
已完结
Exogenous RNA surveillance by proton-sensing TRIM25
4个月前
已完结
皖公网安备34019202002308
